COVID-19 Impact on Global OTC Gastrointestinal Products Market Insights, Forecast to 2026
OTC gastrointestinal agents include many different classes of drugs that are used to treat gastrointestinal disorders.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Gastrointestinal Products market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the OTC Gastrointestinal Products industry.
Based on our recent survey, we have several different scenarios about the OTC Gastrointestinal Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of OTC Gastrointestinal Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Gastrointestinal Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Gastrointestinal Products market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global OTC Gastrointestinal Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global OTC Gastrointestinal Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global OTC Gastrointestinal Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global OTC Gastrointestinal Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Gastrointestinal Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Gastrointestinal Products market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the OTC Gastrointestinal Products market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the OTC Gastrointestinal Products industry.
Based on our recent survey, we have several different scenarios about the OTC Gastrointestinal Products YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of OTC Gastrointestinal Products will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global OTC Gastrointestinal Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global OTC Gastrointestinal Products market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global OTC Gastrointestinal Products market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global OTC Gastrointestinal Products market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global OTC Gastrointestinal Products market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global OTC Gastrointestinal Products market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global OTC Gastrointestinal Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global OTC Gastrointestinal Products market.
The following manufacturers are covered in this report:
- GlaxoSmithKline
- Merck
- Novartis
- Bayer
- Pfizer
- Bristol-Myers Squibb
- H2 Receptor Antagonists
- Proton Pump Inhibitors (PPIs)
- Hospital Pharmacies
- Drug Stores
- Retail Stores
- E-Commerce
1 STUDY COVERAGE
1.1 OTC Gastrointestinal Products Product Introduction
1.2 Market Segments
1.3 Key OTC Gastrointestinal Products Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Gastrointestinal Products Market Size Growth Rate by Type
1.4.2 H2 Receptor Antagonists
1.4.3 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global OTC Gastrointestinal Products Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Coronavirus Disease 2019 (Covid-19): OTC Gastrointestinal Products Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Gastrointestinal Products Industry
1.6.1.1 OTC Gastrointestinal Products Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Gastrointestinal Products Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Gastrointestinal Products Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts
2.1.1 Global OTC Gastrointestinal Products Revenue 2015-2026
2.1.2 Global OTC Gastrointestinal Products Sales 2015-2026
2.2 OTC Gastrointestinal Products Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Gastrointestinal Products Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Gastrointestinal Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OTC GASTROINTESTINAL PRODUCTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 OTC Gastrointestinal Products Sales by Manufacturers
3.1.1 OTC Gastrointestinal Products Sales by Manufacturers (2015-2020)
3.1.2 OTC Gastrointestinal Products Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Gastrointestinal Products Revenue by Manufacturers
3.2.1 OTC Gastrointestinal Products Revenue by Manufacturers (2015-2020)
3.2.2 OTC Gastrointestinal Products Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Gastrointestinal Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Gastrointestinal Products Revenue in 2019
3.2.5 Global OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Gastrointestinal Products Price by Manufacturers
3.4 OTC Gastrointestinal Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Gastrointestinal Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Gastrointestinal Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Gastrointestinal Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global OTC Gastrointestinal Products Market Size by Type (2015-2020)
4.1.1 Global OTC Gastrointestinal Products Sales by Type (2015-2020)
4.1.2 Global OTC Gastrointestinal Products Revenue by Type (2015-2020)
4.1.3 OTC Gastrointestinal Products Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Gastrointestinal Products Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Gastrointestinal Products Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Gastrointestinal Products Revenue Forecast by Type (2021-2026)
4.2.3 OTC Gastrointestinal Products Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Gastrointestinal Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global OTC Gastrointestinal Products Market Size by Application (2015-2020)
5.1.1 Global OTC Gastrointestinal Products Sales by Application (2015-2020)
5.1.2 Global OTC Gastrointestinal Products Revenue by Application (2015-2020)
5.1.3 OTC Gastrointestinal Products Price by Application (2015-2020)
5.2 OTC Gastrointestinal Products Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Gastrointestinal Products Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Gastrointestinal Products Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Gastrointestinal Products Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Gastrointestinal Products by Country
6.1.1 North America OTC Gastrointestinal Products Sales by Country
6.1.2 North America OTC Gastrointestinal Products Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Gastrointestinal Products Market Facts & Figures by Type
6.3 North America OTC Gastrointestinal Products Market Facts & Figures by Application
7 EUROPE
7.1 Europe OTC Gastrointestinal Products by Country
7.1.1 Europe OTC Gastrointestinal Products Sales by Country
7.1.2 Europe OTC Gastrointestinal Products Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Gastrointestinal Products Market Facts & Figures by Type
7.3 Europe OTC Gastrointestinal Products Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific OTC Gastrointestinal Products by Region
8.1.1 Asia Pacific OTC Gastrointestinal Products Sales by Region
8.1.2 Asia Pacific OTC Gastrointestinal Products Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Type
8.3 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America OTC Gastrointestinal Products by Country
9.1.1 Latin America OTC Gastrointestinal Products Sales by Country
9.1.2 Latin America OTC Gastrointestinal Products Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Gastrointestinal Products Market Facts & Figures by Type
9.3 Central & South America OTC Gastrointestinal Products Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa OTC Gastrointestinal Products by Country
10.1.1 Middle East and Africa OTC Gastrointestinal Products Sales by Country
10.1.2 Middle East and Africa OTC Gastrointestinal Products Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Type
10.3 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Gastrointestinal Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck OTC Gastrointestinal Products Products Offered
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis OTC Gastrointestinal Products Products Offered
11.3.5 Novartis Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer OTC Gastrointestinal Products Products Offered
11.4.5 Bayer Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer OTC Gastrointestinal Products Products Offered
11.5.5 Pfizer Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Gastrointestinal Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 OTC Gastrointestinal Products Market Estimates and Projections by Region
12.1.1 Global OTC Gastrointestinal Products Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Gastrointestinal Products Revenue Forecast by Regions 2021-2026
12.2 North America OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.2.1 North America: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.2.2 North America: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.2.3 North America: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.3.2 Europe: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Gastrointestinal Products Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OTC Gastrointestinal Products Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 OTC Gastrointestinal Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 OTC Gastrointestinal Products Product Introduction
1.2 Market Segments
1.3 Key OTC Gastrointestinal Products Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global OTC Gastrointestinal Products Market Size Growth Rate by Type
1.4.2 H2 Receptor Antagonists
1.4.3 Proton Pump Inhibitors (PPIs)
1.5 Market by Application
1.5.1 Global OTC Gastrointestinal Products Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 Retail Stores
1.5.5 E-Commerce
1.6 Coronavirus Disease 2019 (Covid-19): OTC Gastrointestinal Products Industry Impact
1.6.1 How the Covid-19 is Affecting the OTC Gastrointestinal Products Industry
1.6.1.1 OTC Gastrointestinal Products Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and OTC Gastrointestinal Products Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for OTC Gastrointestinal Products Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global OTC Gastrointestinal Products Market Size Estimates and Forecasts
2.1.1 Global OTC Gastrointestinal Products Revenue 2015-2026
2.1.2 Global OTC Gastrointestinal Products Sales 2015-2026
2.2 OTC Gastrointestinal Products Market Size by Region: 2020 Versus 2026
2.2.1 Global OTC Gastrointestinal Products Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global OTC Gastrointestinal Products Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OTC GASTROINTESTINAL PRODUCTS COMPETITOR LANDSCAPE BY PLAYERS
3.1 OTC Gastrointestinal Products Sales by Manufacturers
3.1.1 OTC Gastrointestinal Products Sales by Manufacturers (2015-2020)
3.1.2 OTC Gastrointestinal Products Sales Market Share by Manufacturers (2015-2020)
3.2 OTC Gastrointestinal Products Revenue by Manufacturers
3.2.1 OTC Gastrointestinal Products Revenue by Manufacturers (2015-2020)
3.2.2 OTC Gastrointestinal Products Revenue Share by Manufacturers (2015-2020)
3.2.3 Global OTC Gastrointestinal Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by OTC Gastrointestinal Products Revenue in 2019
3.2.5 Global OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 OTC Gastrointestinal Products Price by Manufacturers
3.4 OTC Gastrointestinal Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Gastrointestinal Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Gastrointestinal Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Gastrointestinal Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global OTC Gastrointestinal Products Market Size by Type (2015-2020)
4.1.1 Global OTC Gastrointestinal Products Sales by Type (2015-2020)
4.1.2 Global OTC Gastrointestinal Products Revenue by Type (2015-2020)
4.1.3 OTC Gastrointestinal Products Average Selling Price (ASP) by Type (2015-2026)
4.2 Global OTC Gastrointestinal Products Market Size Forecast by Type (2021-2026)
4.2.1 Global OTC Gastrointestinal Products Sales Forecast by Type (2021-2026)
4.2.2 Global OTC Gastrointestinal Products Revenue Forecast by Type (2021-2026)
4.2.3 OTC Gastrointestinal Products Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global OTC Gastrointestinal Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global OTC Gastrointestinal Products Market Size by Application (2015-2020)
5.1.1 Global OTC Gastrointestinal Products Sales by Application (2015-2020)
5.1.2 Global OTC Gastrointestinal Products Revenue by Application (2015-2020)
5.1.3 OTC Gastrointestinal Products Price by Application (2015-2020)
5.2 OTC Gastrointestinal Products Market Size Forecast by Application (2021-2026)
5.2.1 Global OTC Gastrointestinal Products Sales Forecast by Application (2021-2026)
5.2.2 Global OTC Gastrointestinal Products Revenue Forecast by Application (2021-2026)
5.2.3 Global OTC Gastrointestinal Products Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America OTC Gastrointestinal Products by Country
6.1.1 North America OTC Gastrointestinal Products Sales by Country
6.1.2 North America OTC Gastrointestinal Products Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America OTC Gastrointestinal Products Market Facts & Figures by Type
6.3 North America OTC Gastrointestinal Products Market Facts & Figures by Application
7 EUROPE
7.1 Europe OTC Gastrointestinal Products by Country
7.1.1 Europe OTC Gastrointestinal Products Sales by Country
7.1.2 Europe OTC Gastrointestinal Products Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe OTC Gastrointestinal Products Market Facts & Figures by Type
7.3 Europe OTC Gastrointestinal Products Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific OTC Gastrointestinal Products by Region
8.1.1 Asia Pacific OTC Gastrointestinal Products Sales by Region
8.1.2 Asia Pacific OTC Gastrointestinal Products Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Type
8.3 Asia Pacific OTC Gastrointestinal Products Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America OTC Gastrointestinal Products by Country
9.1.1 Latin America OTC Gastrointestinal Products Sales by Country
9.1.2 Latin America OTC Gastrointestinal Products Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America OTC Gastrointestinal Products Market Facts & Figures by Type
9.3 Central & South America OTC Gastrointestinal Products Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa OTC Gastrointestinal Products by Country
10.1.1 Middle East and Africa OTC Gastrointestinal Products Sales by Country
10.1.2 Middle East and Africa OTC Gastrointestinal Products Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Type
10.3 Middle East and Africa OTC Gastrointestinal Products Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Gastrointestinal Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description, Business Overview and Total Revenue
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck OTC Gastrointestinal Products Products Offered
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description, Business Overview and Total Revenue
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis OTC Gastrointestinal Products Products Offered
11.3.5 Novartis Recent Development
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description, Business Overview and Total Revenue
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer OTC Gastrointestinal Products Products Offered
11.4.5 Bayer Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer OTC Gastrointestinal Products Products Offered
11.5.5 Pfizer Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb OTC Gastrointestinal Products Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline OTC Gastrointestinal Products Products Offered
11.1.5 GlaxoSmithKline Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 OTC Gastrointestinal Products Market Estimates and Projections by Region
12.1.1 Global OTC Gastrointestinal Products Sales Forecast by Regions 2021-2026
12.1.2 Global OTC Gastrointestinal Products Revenue Forecast by Regions 2021-2026
12.2 North America OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.2.1 North America: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.2.2 North America: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.2.3 North America: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
12.3 Europe OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.3.1 Europe: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.3.2 Europe: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.3.3 Europe: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.4.2 Asia Pacific: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: OTC Gastrointestinal Products Market Size Forecast by Region (2021-2026)
12.5 Latin America OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.5.1 Latin America: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.5.2 Latin America: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.5.3 Latin America: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa OTC Gastrointestinal Products Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: OTC Gastrointestinal Products Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: OTC Gastrointestinal Products Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: OTC Gastrointestinal Products Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key OTC Gastrointestinal Products Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 OTC Gastrointestinal Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. OTC Gastrointestinal Products Market Segments
Table 2. Ranking of Global Top OTC Gastrointestinal Products Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Gastrointestinal Products Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of H2 Receptor Antagonists
Table 5. Major Manufacturers of Proton Pump Inhibitors (PPIs)
Table 6. COVID-19 Impact Global Market: (Four OTC Gastrointestinal Products Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for OTC Gastrointestinal Products Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for OTC Gastrointestinal Products Players to Combat Covid-19 Impact
Table 11. Global OTC Gastrointestinal Products Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global OTC Gastrointestinal Products Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global OTC Gastrointestinal Products Sales by Regions 2015-2020 (K Units)
Table 14. Global OTC Gastrointestinal Products Sales Market Share by Regions (2015-2020)
Table 15. Global OTC Gastrointestinal Products Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global OTC Gastrointestinal Products Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global OTC Gastrointestinal Products Sales Share by Manufacturers (2015-2020)
Table 18. Global OTC Gastrointestinal Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global OTC Gastrointestinal Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Gastrointestinal Products as of 2019)
Table 20. OTC Gastrointestinal Products Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. OTC Gastrointestinal Products Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers OTC Gastrointestinal Products Price (2015-2020) (USD/Unit)
Table 23. OTC Gastrointestinal Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers OTC Gastrointestinal Products Product Type
Table 25. Date of International Manufacturers Enter into OTC Gastrointestinal Products Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 28. Global OTC Gastrointestinal Products Sales Share by Type (2015-2020)
Table 29. Global OTC Gastrointestinal Products Revenue by Type (2015-2020) (US$ Million)
Table 30. Global OTC Gastrointestinal Products Revenue Share by Type (2015-2020)
Table 31. OTC Gastrointestinal Products Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 33. Global OTC Gastrointestinal Products Sales Share by Application (2015-2020)
Table 34. North America OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 35. North America OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 36. North America OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 37. North America OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 38. North America OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 39. North America OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 40. North America OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 41. North America OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 42. Europe OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 43. Europe OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 44. Europe OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 46. Europe OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 47. Europe OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 48. Europe OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 49. Europe OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific OTC Gastrointestinal Products Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific OTC Gastrointestinal Products Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific OTC Gastrointestinal Products Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 58. Latin America OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 59. Latin America OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 62. Latin America OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 63. Latin America OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 64. Latin America OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 65. Latin America OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Major Businesses
Table 91. Bayer OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Bayer Product
Table 93. Bayer Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Bristol-Myers Squibb Corporation Information
Table 100. Bristol-Myers Squibb Description and Major Businesses
Table 101. Bristol-Myers Squibb OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Global OTC Gastrointestinal Products Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global OTC Gastrointestinal Products Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global OTC Gastrointestinal Products Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global OTC Gastrointestinal Products Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: OTC Gastrointestinal Products Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: OTC Gastrointestinal Products Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key OTC Gastrointestinal Products Players
Table 122. OTC Gastrointestinal Products Customers List
Table 123. OTC Gastrointestinal Products Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. OTC Gastrointestinal Products Market Segments
Table 2. Ranking of Global Top OTC Gastrointestinal Products Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global OTC Gastrointestinal Products Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of H2 Receptor Antagonists
Table 5. Major Manufacturers of Proton Pump Inhibitors (PPIs)
Table 6. COVID-19 Impact Global Market: (Four OTC Gastrointestinal Products Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for OTC Gastrointestinal Products Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for OTC Gastrointestinal Products Players to Combat Covid-19 Impact
Table 11. Global OTC Gastrointestinal Products Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global OTC Gastrointestinal Products Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global OTC Gastrointestinal Products Sales by Regions 2015-2020 (K Units)
Table 14. Global OTC Gastrointestinal Products Sales Market Share by Regions (2015-2020)
Table 15. Global OTC Gastrointestinal Products Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global OTC Gastrointestinal Products Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global OTC Gastrointestinal Products Sales Share by Manufacturers (2015-2020)
Table 18. Global OTC Gastrointestinal Products Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global OTC Gastrointestinal Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Gastrointestinal Products as of 2019)
Table 20. OTC Gastrointestinal Products Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. OTC Gastrointestinal Products Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers OTC Gastrointestinal Products Price (2015-2020) (USD/Unit)
Table 23. OTC Gastrointestinal Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers OTC Gastrointestinal Products Product Type
Table 25. Date of International Manufacturers Enter into OTC Gastrointestinal Products Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 28. Global OTC Gastrointestinal Products Sales Share by Type (2015-2020)
Table 29. Global OTC Gastrointestinal Products Revenue by Type (2015-2020) (US$ Million)
Table 30. Global OTC Gastrointestinal Products Revenue Share by Type (2015-2020)
Table 31. OTC Gastrointestinal Products Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 33. Global OTC Gastrointestinal Products Sales Share by Application (2015-2020)
Table 34. North America OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 35. North America OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 36. North America OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 37. North America OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 38. North America OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 39. North America OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 40. North America OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 41. North America OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 42. Europe OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 43. Europe OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 44. Europe OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 46. Europe OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 47. Europe OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 48. Europe OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 49. Europe OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific OTC Gastrointestinal Products Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific OTC Gastrointestinal Products Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific OTC Gastrointestinal Products Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 58. Latin America OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 59. Latin America OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 62. Latin America OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 63. Latin America OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 64. Latin America OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 65. Latin America OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa OTC Gastrointestinal Products Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa OTC Gastrointestinal Products Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa OTC Gastrointestinal Products Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa OTC Gastrointestinal Products Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa OTC Gastrointestinal Products Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Major Businesses
Table 81. Merck OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Major Businesses
Table 91. Bayer OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Bayer Product
Table 93. Bayer Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Bristol-Myers Squibb Corporation Information
Table 100. Bristol-Myers Squibb Description and Major Businesses
Table 101. Bristol-Myers Squibb OTC Gastrointestinal Products Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Global OTC Gastrointestinal Products Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global OTC Gastrointestinal Products Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global OTC Gastrointestinal Products Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global OTC Gastrointestinal Products Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: OTC Gastrointestinal Products Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: OTC Gastrointestinal Products Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: OTC Gastrointestinal Products Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: OTC Gastrointestinal Products Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key OTC Gastrointestinal Products Players
Table 122. OTC Gastrointestinal Products Customers List
Table 123. OTC Gastrointestinal Products Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. OTC Gastrointestinal Products Product Picture
Figure 2. Global OTC Gastrointestinal Products Sales Market Share by Type in 2020 & 2026
Figure 3. H2 Receptor Antagonists Product Picture
Figure 4. Proton Pump Inhibitors (PPIs) Product Picture
Figure 5. Global OTC Gastrointestinal Products Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Drug Stores
Figure 8. Retail Stores
Figure 9. E-Commerce
Figure 10. OTC Gastrointestinal Products Report Years Considered
Figure 11. Global OTC Gastrointestinal Products Market Size 2015-2026 (US$ Million)
Figure 12. Global OTC Gastrointestinal Products Sales 2015-2026 (K Units)
Figure 13. Global OTC Gastrointestinal Products Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global OTC Gastrointestinal Products Sales Market Share by Region (2015-2020)
Figure 15. Global OTC Gastrointestinal Products Sales Market Share by Region in 2019
Figure 16. Global OTC Gastrointestinal Products Revenue Market Share by Region (2015-2020)
Figure 17. Global OTC Gastrointestinal Products Revenue Market Share by Region in 2019
Figure 18. Global OTC Gastrointestinal Products Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by OTC Gastrointestinal Products Revenue in 2019
Figure 20. OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Figure 22. Global OTC Gastrointestinal Products Sales Market Share by Type in 2019
Figure 23. Global OTC Gastrointestinal Products Revenue Market Share by Type (2015-2020)
Figure 24. Global OTC Gastrointestinal Products Revenue Market Share by Type in 2019
Figure 25. Global OTC Gastrointestinal Products Market Share by Price Range (2015-2020)
Figure 26. Global OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Figure 27. Global OTC Gastrointestinal Products Sales Market Share by Application in 2019
Figure 28. Global OTC Gastrointestinal Products Revenue Market Share by Application (2015-2020)
Figure 29. Global OTC Gastrointestinal Products Revenue Market Share by Application in 2019
Figure 30. North America OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 33. North America OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 34. U.S. OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America OTC Gastrointestinal Products Market Share by Type in 2019
Figure 39. North America OTC Gastrointestinal Products Market Share by Application in 2019
Figure 40. Europe OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 43. Europe OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 44. Germany OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 47. France OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe OTC Gastrointestinal Products Market Share by Type in 2019
Figure 55. Europe OTC Gastrointestinal Products Market Share by Application in 2019
Figure 56. Asia Pacific OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Region in 2019
Figure 59. Asia Pacific OTC Gastrointestinal Products Revenue Market Share by Region in 2019
Figure 60. China OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 61. China OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 67. India OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific OTC Gastrointestinal Products Market Share by Type in 2019
Figure 83. Asia Pacific OTC Gastrointestinal Products Market Share by Application in 2019
Figure 84. Latin America OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 87. Latin America OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 88. Mexico OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America OTC Gastrointestinal Products Market Share by Type in 2019
Figure 95. Latin America OTC Gastrointestinal Products Market Share by Application in 2019
Figure 96. Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 99. Middle East and Africa OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 100. Turkey OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa OTC Gastrointestinal Products Market Share by Type in 2019
Figure 107. Middle East and Africa OTC Gastrointestinal Products Market Share by Application in 2019
Figure 108. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. OTC Gastrointestinal Products Product Picture
Figure 2. Global OTC Gastrointestinal Products Sales Market Share by Type in 2020 & 2026
Figure 3. H2 Receptor Antagonists Product Picture
Figure 4. Proton Pump Inhibitors (PPIs) Product Picture
Figure 5. Global OTC Gastrointestinal Products Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Drug Stores
Figure 8. Retail Stores
Figure 9. E-Commerce
Figure 10. OTC Gastrointestinal Products Report Years Considered
Figure 11. Global OTC Gastrointestinal Products Market Size 2015-2026 (US$ Million)
Figure 12. Global OTC Gastrointestinal Products Sales 2015-2026 (K Units)
Figure 13. Global OTC Gastrointestinal Products Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global OTC Gastrointestinal Products Sales Market Share by Region (2015-2020)
Figure 15. Global OTC Gastrointestinal Products Sales Market Share by Region in 2019
Figure 16. Global OTC Gastrointestinal Products Revenue Market Share by Region (2015-2020)
Figure 17. Global OTC Gastrointestinal Products Revenue Market Share by Region in 2019
Figure 18. Global OTC Gastrointestinal Products Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by OTC Gastrointestinal Products Revenue in 2019
Figure 20. OTC Gastrointestinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global OTC Gastrointestinal Products Sales Market Share by Type (2015-2020)
Figure 22. Global OTC Gastrointestinal Products Sales Market Share by Type in 2019
Figure 23. Global OTC Gastrointestinal Products Revenue Market Share by Type (2015-2020)
Figure 24. Global OTC Gastrointestinal Products Revenue Market Share by Type in 2019
Figure 25. Global OTC Gastrointestinal Products Market Share by Price Range (2015-2020)
Figure 26. Global OTC Gastrointestinal Products Sales Market Share by Application (2015-2020)
Figure 27. Global OTC Gastrointestinal Products Sales Market Share by Application in 2019
Figure 28. Global OTC Gastrointestinal Products Revenue Market Share by Application (2015-2020)
Figure 29. Global OTC Gastrointestinal Products Revenue Market Share by Application in 2019
Figure 30. North America OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 33. North America OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 34. U.S. OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America OTC Gastrointestinal Products Market Share by Type in 2019
Figure 39. North America OTC Gastrointestinal Products Market Share by Application in 2019
Figure 40. Europe OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 43. Europe OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 44. Germany OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 47. France OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe OTC Gastrointestinal Products Market Share by Type in 2019
Figure 55. Europe OTC Gastrointestinal Products Market Share by Application in 2019
Figure 56. Asia Pacific OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific OTC Gastrointestinal Products Sales Market Share by Region in 2019
Figure 59. Asia Pacific OTC Gastrointestinal Products Revenue Market Share by Region in 2019
Figure 60. China OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 61. China OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 67. India OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific OTC Gastrointestinal Products Market Share by Type in 2019
Figure 83. Asia Pacific OTC Gastrointestinal Products Market Share by Application in 2019
Figure 84. Latin America OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 87. Latin America OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 88. Mexico OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America OTC Gastrointestinal Products Market Share by Type in 2019
Figure 95. Latin America OTC Gastrointestinal Products Market Share by Application in 2019
Figure 96. Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa OTC Gastrointestinal Products Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa OTC Gastrointestinal Products Sales Market Share by Country in 2019
Figure 99. Middle East and Africa OTC Gastrointestinal Products Revenue Market Share by Country in 2019
Figure 100. Turkey OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E OTC Gastrointestinal Products Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E OTC Gastrointestinal Products Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa OTC Gastrointestinal Products Market Share by Type in 2019
Figure 107. Middle East and Africa OTC Gastrointestinal Products Market Share by Application in 2019
Figure 108. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa OTC Gastrointestinal Products Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa OTC Gastrointestinal Products Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
